Cargando…
Mild behavioral impairment: measurement and clinical correlates of a novel marker of preclinical Alzheimer’s disease
BACKGROUND: Late-life onset neuropsychiatric symptoms are established risk factors for dementia. The mild behavioral impairment (MBI) diagnostic framework was designed to standardize assessment to determine dementia risk better. In this Mini Review, we summarize the emerging clinical and biomarker e...
Autores principales: | Creese, Byron, Ismail, Zahinoor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8734161/ https://www.ncbi.nlm.nih.gov/pubmed/34986891 http://dx.doi.org/10.1186/s13195-021-00949-7 |
Ejemplares similares
-
Optimizing detection of Alzheimer’s disease in mild cognitive impairment: a 4-year biomarker study of mild behavioral impairment in ADNI and MEMENTO
por: Ismail, Zahinoor, et al.
Publicado: (2023) -
Genetic risk for Alzheimer's disease, cognition, and mild behavioral impairment in healthy older adults
por: Creese, Byron, et al.
Publicado: (2021) -
Mild behavioral impairment and its relation to tau pathology in preclinical Alzheimer’s disease
por: Johansson, Maurits, et al.
Publicado: (2021) -
Late‐life onset psychotic symptoms and incident cognitive impairment in people without dementia: Modification by genetic risk for Alzheimer's disease
por: Creese, Byron, et al.
Publicado: (2023) -
Prevalence of Mild Behavioral Impairment and Risk of Dementia in a Psychiatric Outpatient Clinic
por: Matsuoka, Teruyuki, et al.
Publicado: (2019)